CompanyNasdaqHudson, MA

Lifeward Ltd

SEC EDGAR ClinicalTrials.gov

8-KOct 1Latest SEC filing

Form DJul 8$11M sold

October 2026

Lifeward taps interim CEO Hexter to also serve as interim finance chief

Oct 1PeopleLifeward Ltd

August 2026

Lifeward CEO Mark Grant departs, Josh Hexter named interim chief

Aug 31PeopleLifeward Ltd

Lifeward overhauls board as Q2 revenue rises 16%, CFO to depart

Aug 20PeopleLifeward Ltd

July 2026

Lifeward Ltd. files Form D for $11.16 million offering under Rule 506(b)

Jul 8FinancingLifeward Ltd

Lifeward amends notes with Oramed, closes $5.58 million convertible note financing

Jul 7PartnershipLifeward Ltd